KRAS and neoplasm: Our study indicates that, if a tumor sample is unavailable or insufficient, using a more sensitive method than PNA-PCR assay such as ultra deep sequencing technology on a plasma DNA sample might be an alternative way to determine KRAS status in metastatic colorectal cancer.